Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1538950A details a mild transfer hydrogenation method for amine synthesis using Ru/Rh catalysts, offering cost reduction in API manufacturing and high optical purity.
Patent CN85103245A details novel rhodium-diphosphine complexes enabling high-yield asymmetric hydrogenation for pharmaceutical intermediates with reduced catalyst loading.
Patent CN101039894A reveals stabilized Rh-catalyzed asymmetric hydrogenation for high-purity citronellal production, offering significant cost reduction in flavor manufacturing.
Novel acenaphthopyrazino quinoxaline synthesis patent CN114507237B enables high quantum efficiency OLED materials with scalable production capabilities for global supply chains.
Patent CN101941900A reveals a novel Ru-catalyzed asymmetric hydrogenation route for high-purity chiral acids, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Novel Ru-BINAP catalyzed route for (R)-5'-methoxylaudanosine. High purity >99.98% ee, non-genotoxic process, scalable for Mivacurium Chloride production.
Novel transfer hydrogenation process ensures safe scalable production of high-purity fluorescent tracers with reduced operational hazards and improved efficiency.
Patent CN102076634A details enantioselective hydrogenation of N-H imines. Discover cost-effective routes for high-purity pharmaceutical intermediates without protection steps.
Novel Rh-catalyzed asymmetric hydrogenation route for Pramipexole. Higher yield, lower cost, industrial scale ready. Ideal for pharma intermediates.
Patent CN114874134A details a protection-free asymmetric synthesis of nicotine using Ir-catalysis, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN103492351B details efficient dehydrogenation oxidation for carbonyl compounds. Enables cost reduction in fine chemical manufacturing and reliable supply chain.
Patent CN1139576C details a novel iridium-catalyzed asymmetric hydrogenation process for producing high-purity dextromethorphan intermediates with enhanced supply chain reliability.
Patent CN114644614B details a novel 3-step synthesis for L-nicotine achieving >99.9% optical purity. Discover cost-effective, scalable manufacturing solutions for pharmaceutical intermediates.
Patent CN114644614B reveals a novel 3-step route to L-nicotine with >99.9% ee. Discover cost-effective manufacturing and supply chain advantages for pharma intermediates.
Patent CN1566084A reveals novel water-soluble diamines enabling green asymmetric hydrogenation. Discover cost-effective API intermediate manufacturing solutions.
Patent CN101346352B reveals efficient Rh-catalyzed asymmetric reduction for Mitiglinide. Offers high optical purity and industrial scalability for diabetes drug intermediates.
Patent CN101346352B reveals a novel rhodium-catalyzed asymmetric reduction for Mitiglinide intermediates, offering superior optical purity and industrial scalability for pharmaceutical manufacturers.
Patent CN112624901B details a novel refining method for chiral alcohols using polymer-supported catalysts and specific ether solvents, ensuring >99% purity for API manufacturing.
Advanced process for pyrazole-O-glycoside derivatives via catalytic hydrogenation and phase transfer glycosylation. Reliable supplier for high-purity pharmaceutical intermediates.
Novel synthesis route for desvenlafaxine succinate offering high purity and cost reduction for pharmaceutical supply chains ensuring reliable global availability and quality.